Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 4Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Head and Neck Neoplasms 2Breast Neoplasms 2Neuroendocrine Tumors 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Large B-cell Lymphoma 1Hypoxia 1Glioma 1Carcinoma, Transitional Cell 1

Interventions

Positron Emission Tomography Computed Tomography 1Ferrosoferric Oxide 1Atovaquone 13-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Hypoxia × Positron Emission Tomography Computed Tomography × Clear all
NCT00395109 2017-08-28

PET/CT to Image Hypoxia in Head and Neck Tumours

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase EARLY_PHASE1 Completed
17 enrolled
Head & Neck

Hypoxia, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡